Skip to main content
OpenTrials
Completed

NCT Number: NCT06167447

Evaluation of the Presence and Effects of Kinesiophobia in Multiple Sclerosis

The aim of this study was to evaluate the presence of kinesiophobia in multiple sclerosis and to investigate the effect of kinesiophobia on physical activity, functional status, quality of life and depression.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multiple Sclerosis Anxiety Disorders Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Immune System Diseases Kinesiophobia Mental Disorders Nervous System Diseases Phobic Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Bilge Nur Kılınç

Ankara, 06550, Turkey (Türkiye)

About this study

90 people, including 45 patients and 45 healthy control groups, were included in the study. Demographic data of all participants were recorded. Tampa Scale of Kinesiophobia (TSK), Beck Depression Inventory (BDI), Quality of Life Scale Short Form-36 (SF-36), International Physical Activity Questionnaire Short Form (IPAQ-SF), Functional Ambulation Classification (FAS), in addition to Multiple Sclerosis group, Functional Independence Measure (FIM), Expanded Disability Status Scale (EDSS) were implemented.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having a definitive diagnosis of MS according to the 2017 Revised McDonald Diagnostic Criteria
  • Expanded Disability Status Scale (EDSS) score between 0-6.5
  • Be between the ages of 18-65
  • Volunteering to participate in the study

Exclusion criteria

  • Having orthopedic, psychiatric and other chronic diseases other than MS that may affect physical and cognitive status
  • Expanded Disability Status Scale (EDSS) score >6.5
  • Being in the MS attack period

Treatment and study plan

questionnaire and examination

Other

Demographic data of all participants, height, weight, body mass index, occupation, marriage status, education level, comorbidities, medications used, duration of illness and subtype will be recorded by the researcher. Questionnaires to be filled by patients. On the same day, the musculoskeletal system and neurological examination of the participants will be evaluated by the researcher.

Primary outcomes

  1. Tampa Scale of Kinesiophobia

    Time frame: through study completion, an average of 6 months.

    Tampa Scale of Kinesiophobia is a checklist of 17 questions developed to measure the fear of movement and re-injury. It is used in many situations such as Acute and chronic pain, Fibromyalgia Syndrome (FMS), musculoskeletal system related injuries, etc. Items in the scale are scored according to a 4-point Likert scoring. A total score of 37 points and above indicates a high level of kinesiophobia.

Sponsors and collaborators

Lead sponsor

Gazi University

Other

Registry information

Official study title

Evaluation Of The Existence Of Kinesiophobia In Patients With Multiple Sclerosis; Effect Of Kinesiophobia On Physical Activity,Functional Status, Quality Of Life and Depression

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Dec 12, 2023
Registry last updated
Dec 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.